It's a risk that Big Pharma has left to little pharma.
And it's not just Benitec.
Big Pharma is quite prepared to pay up rather than see their reputations suffer a failure.
Our next two clinical targets, NSCLC and the ARMD are a very good second and third choice especially if we fail to 'deliver to the liver'.
- Forums
- ASX - By Stock
- BLT
- eye diseases and ddrnai
eye diseases and ddrnai, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online